QT
BEAM icon

Quantamental Technologies’s Beam Therapeutics BEAM Stock Holding History

Quantamental Technologies’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,354
Closed -$636K – 464
2022
Q3 		$636K Buy
+13,354
New +$762K 0.25% 139

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Quantamental Technologies's BEAM Position: Q4 2022 in Review

Quantamental Technologies sold out of Beam Therapeutics (BEAM) in Q4 2022, closing a stake of 13,354 shares — an estimated $636K sold.

Quantamental Technologies first reported a position in BEAM in Q3 2022 and held it in 1 quarter. The position peaked at $636K in Q3 2022. 209 funds tracked by Wall St. Rank hold BEAM as of Q4 2022.

  • Quantamental Technologies reported no remaining Beam Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Quantamental Technologies sold 13,354 Beam Therapeutics shares in Q4 2022, an estimated $636K.
  • Quantamental Technologies first reported a position in Beam Therapeutics in Q3 2022 and held it in 1 quarter.
  • Quantamental Technologies's Beam Therapeutics position peaked at $636K in Q3 2022.
  • 209 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2022.

Based on Quantamental Technologies's 13F filing for Q4 2022, filed 14 Feb 2023.